Discover why Veeva Vault value plateaus after go-live — and how a lifecycle operating model reduces compliance risk, cuts costs, and prepares your platform for AI.
Most clinical-stage biotechs celebrate Phase 3 wins without realizing their GxP infrastructure isn't ready for NDA-level FDA scrutiny. Here are the 5 gaps that derail NDA submissions — and how to close them.
A cyberattack on Stryker wiped systems globally—what it reveals about hidden third-party risk in clinical trials and what biotech and pharma sponsors should do now.
Join USDM at BoxWorks 2025 to explore AI-driven content management excellence with compliance built-in. Power smarter, compliant content management for life sciences.
